2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVOX 2倍做多NVO ETF-Defiance

休市中 07-02 16:00:00 EDT

17.75

+1.11

+6.67%

盘后17.71

-0.04-0.23%

19:15 EDT

最高18.04	最低17.33	成交量35.92万
今开17.33	昨收16.64	日振幅4.28%
总市值5,712万	流通市值5,712万	总股本321.81万
成交额636.15万	换手率11.16%	流通股本321.81万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":17.75,"timestamp":1783022400000,"preClose":16.64,"halted":0,"volume":359178,"hourTrading":{"tag":"盘后","latestPrice":17.71,"preClose":17.75,"latestTime":"19:15 EDT","volume":1796,"amount":31666.78,"timestamp":1783034107049,"change":-0.04,"changeRate":-0.002254,"amplitude":0.008451},"delay":0,"changeRate":0.06670673076923073,"floatShares":3218101,"shares":3218101,"eps":0,"marketStatus":"休市中","change":1.11,"latestTime":"07-02 16:00:00 EDT","open":17.33,"high":18.0425,"low":17.33,"amount":6361531.939614,"amplitude":0.042819,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":16.64,"sharesOutstanding":4128101,"nav":17.73,"aum":55106630.73,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":17.374,"preClose":16.58,"latestTime":"09:29 EDT","volume":4696,"amount":79779.73352,"timestamp":1782998987468,"change":0.794,"changeRate":0.047889,"amplitude":0.05573},"postHourTrading":{"tag":"盘后","latestPrice":17.71,"preClose":17.75,"latestTime":"19:15 EDT","volume":1796,"amount":31666.78,"timestamp":1783034107049,"change":-0.04,"changeRate":-0.002254,"amplitude":0.008451},"volumeRatio":0.9487666339406076,"impliedVol":0.7804,"impliedVolPercentile":0.3},"requestUrl":"/m/hq/s/NVOX","defaultTab":"news","newsList":[{"id":"2648685208","title":"诺和诺德(NVO)涨3.8% 施压供应商争取折扣 削减成本反攻减肥药市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2648685208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648685208?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:24","pubTimestamp":1783002296,"startTime":"0","endTime":"0","summary":"消息面上，丹麦药企诺和诺德发函合作供应商，协商压低采购成本，意图扭转减肥药市场竞争劣势，抢夺礼来  占据的行业龙头地位。诺和诺德表示供应商参与让利并非强制要求，但让利成效将纳入后续合作评估维度。降本举措并非单一动作，今年 9 月诺和诺德推出大规模裁员计划，拟全球裁减 9000 名员工，叠加本次供应链压价，共同组成新任 CEO 主导的全面降本方案，依托压缩开支优化产品定价，争夺减肥药赛道市场份额。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/NTE3MzYyMzA2NDI2MjU=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NTE3MzYyMzA2NDI2MjU=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302165","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","LU2087625088.SGD","LU0456855351.SGD","LU2236285917.USD","LU0320765059.SGD","LU2461242641.AUD","LU0198837287.USD","LU2361044865.SGD","IE00B1XK9C88.USD","LU2271345857.HKD","LLY","LU1868836914.USD","LU1551013425.SGD","LU1917777945.USD","NVO","LU0466842654.USD","IE00BJLML261.HKD","LU0889565916.HKD","LU2360106947.USD","LU0432979614.USD","LU0353189680.USD","LU1629891620.HKD","BK4581","ELIS","LU2106854487.HKD","BK4007","LU2023250330.USD","BK4585","LU0234572021.USD","LU0471298694.HKD","LU1720051108.HKD","LU2746668974.SGD","LU2552382132.HKD","IE00BJJMRZ35.SGD","LU1064131342.USD","IE00B2B36J28.USD","LU2089284900.SGD","SG9999014906.USD","SGXZ57979304.SGD","LU0823416689.USD","LU0708995401.HKD","LU2168564495.EUR","LU2896262040.SGD","LU1366192091.USD","LU1035775433.USD","LU0203201768.USD","SG9999014880.SGD","IE00BK4W5M84.HKD","LU0820561909.HKD","LU1720051017.SGD","BK4532","LU1145028129.USD","LU1868836757.USD","LU0943347566.SGD","LU2491049909.HKD","LLII","LU0133085943.USD","LU0823434583.USD","LU1093756168.USD","LU2168564149.EUR","LU2237443622.USD","LU2361045086.USD","SG9999015986.USD","IE0002141913.USD","LU2213496289.HKD","LU2265009873.SGD","LU1267930730.SGD","LU1983299246.USD","IE00B7KXQ091.USD","LU2168564222.USD","LU0787776722.HKD","LU0225283273.USD","LU2462157665.USD","SG9999018865.SGD","LU0097036916.USD","LU2357305700.SGD","LU2417539215.USD","SG9999013999.USD","LU1023059063.AUD","BK4516","LU0471298777.SGD","LLYX","LU2237438978.USD","LU0158827781.USD","BK4533","IE00BWXC8680.SGD","LU2361044949.HKD","LU2602419157.SGD","LU0256863902.USD","LU1548497426.USD","LU2750360641.GBP","LU0256863811.USD","LU0820561818.USD","NVOX","BK4534","LU2750360997.AUD","SG9999014914.USD","LU1069344957.HKD","LU1323610961.USD","LU0683600562.USD","LU0079474960.USD","LU2471134523.USD","LU2471134952.CNY","LU1061106388.HKD","LU2023250504.SGD","IE00BZ1G4Q59.USD","LU0385154629.USD","IE00BJT1NW94.SGD","SGXZ99366536.SGD","LU1551013342.USD","LU0210536198.USD","LU2491050071.SGD","LU2108987350.USD","SGXZ51526630.SGD","LU2756315318.SGD","LU2471134879.HKD","LU0122379950.USD","LU2112291526.USD","LU0006306889.USD","SG9999014898.SGD","LU2756315664.SGD","IE0005OL40V9.USD","LU1974910355.USD","IE00BFTCPJ56.SGD","LU1623119135.USD","IE00B4JS1V06.HKD","LU2168564065.EUR","LU2746668461.USD","LU0109394709.USD","IE0004445239.USD","LU0823434740.USD","LU1868837136.USD","LU2468319806.SGD","LU2491050154.USD","LU2063271972.USD","LU0266013472.USD","SG9999015945.SGD","LU2089984988.USD","IE00BKDWB100.SGD","SG9999015978.USD","LU0353189763.USD","LU0058720904.USD","LU1093756325.SGD","LU0203202063.USD","LU2237443978.SGD","IE00B4R5TH58.HKD","BK4588","LU0882574139.USD","ELIL","LU0114720955.EUR","IE00BFSS7M15.SGD","GB00BDT5M118.USD","LU1804176565.USD","LU2237443549.SGD","LU0417517546.SGD","LU0345770308.USD","LU1057294990.SGD","LU1989771016.USD","LU0316494557.USD","IE00BKVL7J92.USD","LU2089283258.USD","LU0289739699.SGD","LU0154236417.USD","IE00BK4W5L77.USD","LU2237443895.HKD","LU2111349929.HKD","LU0354030438.USD","LU1291159041.SGD","LU2456880835.USD","LU1127390331.HKD","LU0106261372.USD","LU2028103732.USD","IE0001KFT4U8.USD","LU0158827948.USD","LU0238689110.USD","LU2552382215.SGD","SGXZ81514606.USD","LU2552382058.USD","LU2324357040.USD","IE00B1BXHZ80.USD","LU0786609619.USD","LU0354030511.USD","LU0689472784.USD","LU0882574055.USD","BK4599","LU0061475181.USD","IE0004445015.USD","LLYZ","IE00BJJMRY28.SGD","LU0323591593.USD","NVOH","LU1868837300.USD","LU2471134796.USD","LU1988902786.USD","LU2023251221.USD","LU2168563687.JPY","LU1868836591.USD","SG9999015952.SGD","LU0820562030.AUD","IE0009355771.USD","IE00BKPKM429.USD","LU0094547139.USD","LU2237443382.USD","SG9999018857.SGD","IE00B775H168.HKD","SG9999001176.SGD","LU0345770993.USD","LU0964807845.USD","LU2237443465.HKD","IE00BJJMRX11.SGD","LU1280957306.USD","SG9999001176.USD","LU2264538146.SGD","SGXZ31699556.SGD","LU1814569148.SGD","LU0320765992.SGD","SG9999017495.SGD","LU0640476718.USD","LU0672654240.SGD","LU1712237335.SGD","LU1232071149.USD","LU2211815571.USD","IE00BN29S564.USD","IE00BFSS8Q28.SGD","LU0109391861.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648651733","title":"诺和诺德：符合条件的联邦医疗保险参保患者现在可按月自付50美元购得Wegovy。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648651733","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648651733?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:01","pubTimestamp":1782903695,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","NVOH","NVOX","NVO","IE00BKVL7J92.USD","LU0154236417.USD","BK4007","BK4585","BK4588","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555250","title":"美国联邦医疗保险七月起首次覆盖减肥药物，诺和诺德股价应声上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555250","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647555250?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:27","pubTimestamp":1782822420,"startTime":"0","endTime":"0","summary":"美国联邦医疗保险周一宣布，自7月1日起将首次覆盖选择性GLP-1类减肥药物，包括诺和诺德生产的司美格鲁肽注射剂。这意味着数千万Medicare参保人将有机会获得这类广受欢迎的减肥药物的报销资格。受此消息提振，诺和诺德股价在周一交易中上涨约0.6%。　　根据美国医疗保险与医疗补助服务中心发布的最终指南，此次覆盖适用于被诊断为肥胖症的患者，即体重指数达到30或以上的人群。此次政策调整是Medicare成立以来首次将减肥药物纳入常规报销体系。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-30/doc-inifexfq1520001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1732800096.USD","LU1791710400.SGD","NVOX","LU1244550577.SGD","LU0557290698.USD","LU1244550494.USD","LU2111349929.HKD","LU0053666078.USD","BK4504","NVOH","LU0314104364.USD","LU0912757837.SGD","LU0158827781.USD","LU0320765646.SGD","LU0210528500.USD","LU0234570918.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","NVO","LU1093756168.USD","LU1093756325.SGD","LU1989772923.USD","BK4516","LU2089283258.USD","LU0882574139.USD","BK4585","LU1548497426.USD","BK4007","LU0267386448.USD","LU1791710582.SGD","BK4588","LU0158827948.USD","LU1363072403.SGD","LU2271345857.HKD","LU2347655156.SGD","LU2357305700.SGD","BK4581","LU2487616109.SGD","LU0390134368.USD","LU0154236417.USD","LU2028103732.USD","LU0528227936.USD","LU1732799900.SGD","LU2023251221.USD","LU0795875169.SGD","LU1988902786.USD","BK4127","LU1720051108.HKD","LU0225283273.USD","LU0006306889.USD","LU2089284900.SGD","LU2133065610.SGD","LU1162221912.USD","LU0971096721.USD","LU1064131342.USD","LU2264538146.SGD","BK4532","LU1668664300.SGD","BK4534","MS","LU0795875086.SGD","LU1244550221.USD","LU0106831901.USD","LU0098860793.USD","LU1989772840.SGD","BK4599","LU1720051017.SGD","LU0106261372.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647581242","title":"杰富瑞将诺和诺德目标股价从270丹麦克朗上调至285丹麦克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2647581242","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647581242?lang=zh_cn&edition=full","pubTime":"2026-06-30 12:03","pubTimestamp":1782792190,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","BK4532","LU1093756168.USD","LU1093756325.SGD","NVOX","BK4007","IE00BKVL7J92.USD","NVOH","BK4599","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646033697","title":"高盛将诺和诺德目标价从305丹麦克朗上调至310丹麦克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646033697","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646033697?lang=zh_cn&edition=full","pubTime":"2026-06-26 13:03","pubTimestamp":1782450188,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ1G4Q59.USD","NVOH","BK4585","IE00BKVL7J92.USD","NVO","LU0154236417.USD","BK4532","BK4588","BK4599","LU1093756325.SGD","NVOX","LU1093756168.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646756628","title":"诺和诺德(NVO.US)美国负责人表示Wegovy口服剂型销量中直接面向消费者的销售占比达90%注射剂型该比例为30%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646756628","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646756628?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:03","pubTimestamp":1782378219,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4532","NVOX","LU1093756325.SGD","LU1093756168.USD","BK4599","IE00BZ1G4Q59.USD","NVOH","NVO","BK4007","LU0154236417.USD","BK4585","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646922817","title":"诺和诺德美国区总裁：公司正寻求小型配套并购，扩充产品管线。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646922817","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646922817?lang=zh_cn&edition=full","pubTime":"2026-06-25 01:21","pubTimestamp":1782321671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","NVOX","NVO","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","LU1093756325.SGD","BK4588","LU0154236417.USD","BK4599","BK4585","NVOH","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646985817","title":"诺和诺德美国区总裁：尚不确定联邦医保是否会立刻加大该处方药报销支持力度。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646985817","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646985817?lang=zh_cn&edition=full","pubTime":"2026-06-25 01:19","pubTimestamp":1782321543,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVO","LU1093756325.SGD","BK4585","IE00BZ1G4Q59.USD","BK4532","LU0154236417.USD","IE00BKVL7J92.USD","NVOH","BK4007","NVOX","BK4599","BK4588","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646081762","title":"诺和诺德美国区总裁：联邦医保患者中，选择口服 GLP‑1 片剂的人数是注射剂的两倍。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646081762","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646081762?lang=zh_cn&edition=full","pubTime":"2026-06-25 01:16","pubTimestamp":1782321382,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4585","NVOH","BK4532","BK4599","LU0154236417.USD","LU1093756325.SGD","BK4007","NVOX","LU1093756168.USD","NVO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645075769","title":"美股异动 | 诺和诺德(NVO.US)涨6% 司美格鲁肽中国市场保护期获延长","url":"https://stock-news.laohu8.com/highlight/detail?id=2645075769","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645075769?lang=zh_cn&edition=full","pubTime":"2026-06-22 23:19","pubTimestamp":1782141582,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，诺和诺德(NVO.US)涨6%，报45.79美元。消息面上，诺和诺德CEO近日明确，公司王牌产品司美格鲁肽在中国的监管数据保护期将持续至2027年4月，这比其核心化合物专利到期日(2026年3月)要晚一年多。据估算，这延长的13个月保护期能为公司带来约10亿美元量级的额外稳定现金流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0154236417.USD","LU1093756325.SGD","NVOH","NVOX","BK4588","LU1093756168.USD","BK4532","BK4599","BK4585","NVO","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644054938","title":"链接世界，共创未来！丹麦诺和诺德公司董事会主席索文森寄语第四届链博会","url":"https://stock-news.laohu8.com/highlight/detail?id=2644054938","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644054938?lang=zh_cn&edition=full","pubTime":"2026-06-19 19:48","pubTimestamp":1781869680,"startTime":"0","endTime":"0","summary":"专题：第四届中国国际供应链促进博览会\n\n　　链接世界，共创未来！丹麦诺和诺德公司董事会主席索文森寄语第四届链博会。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张恒星","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-06-19/doc-inicxyys2720832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4599","NVOH","NVOX","NVO","IE00BKVL7J92.USD","LU0154236417.USD","BK4007","BK4585","BK4588","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644715895","title":"诺和诺德全球CEO：未来会增加在中国的BD交易，口服减重版司美将递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2644715895","media":"澎湃新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644715895?lang=zh_cn&edition=full","pubTime":"2026-06-17 14:22","pubTimestamp":1781677320,"startTime":"0","endTime":"0","summary":"“我们一直与许多中国公司对话，并将继续下去。当我们找到合适的公司或分子，能补充我们感兴趣的领域时，我们不会犹豫提出报价。”6月16日，诺和诺德公司全球总裁兼首席执行官杜麦克（MaziarMikeDoustdar）在接受澎湃新闻记者采访时表示，未来诺和诺德在中国的BD交易会增加，这是肯定的。近几年，BD（业务拓展）已成为中国创新药出海的重要路径。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606173774451184.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606173774451184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVOX","IE00BKVL7J92.USD","BK4532","LU0154236417.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","BK4599","BK4588","BK4585","NVOH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644796603","title":"诺和诺德遭黑客组织窃取大量数据并勒索2500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644796603","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644796603?lang=zh_cn&edition=full","pubTime":"2026-06-17 07:59","pubTimestamp":1781654340,"startTime":"0","endTime":"0","summary":"一个网络勒索组织周二声称，他们从制药巨头诺和诺德公司窃取了超过 1TB 的数据，在向该公司索要2500万美元赎金未果后，正在考虑出售部分数据。　　这个名为FulcrumSec的网络勒索组织于2025年10月成立。该组织在其网站上发布长文称，他们潜入诺和诺德的网络长达两个多月，窃取了相关数据。　　FulcrumSec在一封电子邮件中表示，诺和诺德公司的代表于6月3日联系了该组织，大约在FulcrumSec首次联系该公司未具名高管48小时后。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-17/doc-inicsmhz3885133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4599","IE00BZ1G4Q59.USD","NVO","NVOH","BK4588","BK4007","LU0154236417.USD","IE00BKVL7J92.USD","NVOX","BK4532","LU1093756325.SGD","LU1093756168.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643757340","title":"上任后首次访华，诺和诺德CEO透露司美格鲁肽口服减重药即将在华递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2643757340","media":"第一财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643757340?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:30","pubTimestamp":1781613031,"startTime":"0","endTime":"0","summary":"6月16日，诺和诺德全球CEO杜麦克（MaziarMikeDoustdar）在北京接受专访时向第一财经记者透露，诺和诺德最快有望于未来数周内递交司美格鲁肽口服减重片剂在华上市申请。杜麦克此次访华是他自去年8月担任公司CEO以来的首次访华，同行的还有公司全球高管及董事会成员。他在采访中向第一财经记者强调，中国是诺和诺德重要的战略性市场，也是仅次于美国的全球第二大市场。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606163773314572.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606163773314572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVOX","IE00BKVL7J92.USD","BK4532","LU0154236417.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","BK4599","BK4588","BK4585","NVOH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643273193","title":"买下上海地铁站核心广告位，减重药巨头国内“混战”升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2643273193","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643273193?lang=zh_cn&edition=full","pubTime":"2026-06-16 14:35","pubTimestamp":1781591705,"startTime":"0","endTime":"0","summary":"最近，在上海核心区域乘坐地铁时，很多人会发现减重药广告开始打进人流密集的地铁站。在2号线等多条地铁线交汇的南京西路站，美团买药联手信达生物以“科学体重管理，让脂肪肝逆转”为名，打出整条长廊的巨幅广告；在仅一站之隔的静安寺地铁站，礼来也挂出“阻塞性睡眠呼吸暂停”（OSA）的科普宣传海报。“减重药广告已经无处不在，想不看见都不行。”有网友感叹道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606163772949792.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606163772949792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0106261372.USD","BK4550","LU0320765992.SGD","LU2756315664.SGD","LU1969619763.USD","BK4532","SG9999003800.SGD","LLYX","LU1551013342.USD","BK4568","LU1548497426.USD","LU2237443465.HKD","LU2023250330.USD","LU1066053197.SGD","BK4534","LU1974910355.USD","IE00BBT3K403.USD","01801","LU0061475181.USD","LU1868837136.USD","IE00BLSP4452.SGD","LU2236285917.USD","LU2361044949.HKD","IE00BK4W5L77.USD","LU2237443382.USD","LU1066051498.USD","IE00B19Z3B42.SGD","LU2491050154.USD","LU0266013472.USD","LU0198837287.USD","SGXZ81514606.USD","LU1035775433.USD","IE0004445015.USD","LU0823434740.USD","LU2361045086.USD","NVOX","LU0203202063.USD","IE00BKPKM429.USD","SG9999017495.SGD","BK1583","LU1023059063.AUD","BK4533","LU2112291526.USD","LU0683600562.USD","LU2023251221.USD","LU1366192091.USD","LU1868837300.USD","LU2097828474.EUR","LU1720051017.SGD","LU0114720955.EUR","LU2461242641.AUD","BK4585","LU2168564149.EUR","SG9999002232.USD","LU0096364046.USD","LU2111349929.HKD","LU0385154629.USD","LU1868836914.USD","SG9999015978.USD","IE0004445239.USD","BK4516","LU2087625088.SGD","LU0306807586.USD","LU2089984988.USD","LU2237443895.HKD","IE00BN29S564.USD","LU2089283258.USD","BK4592","LU1712237335.SGD","LU1057294990.SGD","LU2602419157.SGD","LU1868836591.USD","SG9999014898.SGD","IE00BFSS8Q28.SGD","SG9999018865.SGD","SG9999014880.SGD","LU0109394709.USD","LU1267930730.SGD","LU2471134879.HKD","LU1868836757.USD","LU2357305700.SGD","LU2471134523.USD","LU0122379950.USD","LU0708995401.HKD","LU2213496289.HKD","LU2552382058.USD","LU0094547139.USD","SG9999001176.USD","LU2097828805.USD","LU2264538146.SGD","NVO","GB00BDT5M118.USD","LU1323610961.USD","LU2468319806.SGD","LU0316494557.USD","LU2746668461.USD","IE00B3T34201.USD","IE00BLSP4239.USD","LU2552382132.HKD","IE00BFSS7M15.SGD","LU0820561909.HKD","LU1061106388.HKD","LU0868494617.USD","LU1291159041.SGD","LU2108987350.USD","IE00B1XK9C88.USD","LU2552382215.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD","LLII","LU1804176565.USD","LU2023250504.SGD","LU2242644610.SGD","LU0882574055.USD","IE00B4JS1V06.HKD","IE0002141913.USD","LU0353189763.USD","LU2746668974.SGD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0289739699.SGD","LU0353189680.USD","IE0002270589.USD","IE00BKVL7J92.USD","LU2462157665.USD","SGXZ57979304.SGD","LU1894683348.USD","LU1988902786.USD","LU0256863811.USD","LU0471298694.HKD","LU2456880835.USD","SGXZ99366536.SGD","LU0985481810.HKD","SG9999011175.SGD","LU0225283273.USD","SGXZ51526630.SGD","LU0006306889.USD","ELIL","LU0502904849.HKD","LU2063271972.USD","LU2237443978.SGD","IE00BJJMRX11.SGD","LU2361044865.SGD","IE00B2B36J28.USD","LU1145028129.USD","LU2237443549.SGD","LU2211815571.USD","LU0689472784.USD","BK4588","LU0306806265.USD","IE00B775H168.HKD","LU0889565916.HKD","LU0321505439.SGD","SGXZ31699556.SGD","LU0882574139.USD","LU1883839398.USD","PFE","LU1623119135.USD","LU2271345857.HKD","LU0225771236.USD","LU0823434583.USD","LU2756315318.SGD","LU0079474960.USD","LU0354030438.USD","SG9999018857.SGD","BK1161","LU1064131342.USD","LU0432979614.USD","LU2106854487.HKD","NVOH","LU1989771016.USD","LU2491050071.SGD","SG9999015952.SGD","SG9999015986.USD","IE00BJJMRZ35.SGD","LU0154236417.USD","LU2896262040.SGD","LU0320765059.SGD","LU0820561818.USD","LU2265009873.SGD","LU0417517546.SGD","LU0321505868.SGD","LU0456855351.SGD","LU2089284900.SGD","LU2097828557.USD","LU1983299246.USD","LU0323591593.USD","LU0466842654.USD","LLY","SG9999015945.SGD","BK4599","LU1280957306.USD","LLYZ","LU1629891620.HKD","LU1917777945.USD","LU0354030511.USD","ELIS","LU2237438978.USD","LU0256863902.USD","LU0787776722.HKD","LU2324357040.USD","LU2750360641.GBP","BK4007","IE0005OL40V9.USD","LU0158827948.USD","LU0823416689.USD","IE00B1BXHZ80.USD","LU0672654240.SGD","LU0158827781.USD","IE0009355771.USD","LU0234572021.USD","SG9999014906.USD","IE00BKDWB100.SGD","LU2028103732.USD","LU2750360997.AUD","SG9999014914.USD","LU1551013425.SGD","LU2168564222.USD","LU2237443622.USD","LU1720051108.HKD","LU2168564065.EUR","LU2097828631.EUR","IE000M9KFDE8.USD","LU2168563687.JPY","BK1589","LU0943347566.SGD","IE00BJLML261.HKD","LU2097828714.EUR","LU0097036916.USD","LU2471134952.CNY","IE00BJJMRY28.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU2596442595.SGD","LU0109391861.USD","LU0471298777.SGD","LU0133085943.USD","LU1093756325.SGD","LU1814569148.SGD","LU2417539215.USD","IE00BFTCPJ56.SGD","LU1232071149.USD","LU0455707207.USD","LU1069344957.HKD","LU1894683264.USD","LU0238689110.USD","IE00B19Z3581.USD","LU2168564495.EUR","IE00BK4W5M84.HKD","LU0820562030.AUD","LU0210536198.USD","LU2328871848.SGD","IE00B4R5TH58.HKD","LU2360106947.USD","LU0640476718.USD","LU2471134796.USD","HK0000165453.HKD","LU0170899867.USD","BK4581","LU0786609619.USD","LU0225284248.USD","LU1127390331.HKD","SG9999001176.SGD","SG9999002224.SGD","IE00BWXC8680.SGD","LU2491049909.HKD","LU2488822045.USD","LU0203201768.USD","SG9999013999.USD","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643206006","title":"（投资中国）诺和诺德将在天津追加投资提升产能","url":"https://stock-news.laohu8.com/highlight/detail?id=2643206006","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643206006?lang=zh_cn&edition=full","pubTime":"2026-06-15 21:21","pubTimestamp":1781529669,"startTime":"0","endTime":"0","summary":"中新社天津6月15日电全球知名的丹麦生物制药企业诺和诺德15日宣布，将向位于天津的战略生产基地追加投资2亿元(人民币，下同)，用于提升1.5毫升畅充注射笔组装产能。此次追加投资系诺和诺德全球高管团队访华期间公布。项目建成后，将显著提高相关产品的产能与供应效率，以满足中国患者日益多元化的用药需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606153771817294.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606153771817294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVOH","IE00BKVL7J92.USD","NVOX","BK4585","BK4532","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","LU1093756168.USD","BK4588","LU0154236417.USD","BK4007","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643321101","title":"诺和诺德长效生长激素诺泽优将于今年暑期在国内全面上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2643321101","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643321101?lang=zh_cn&edition=full","pubTime":"2026-06-13 17:23","pubTimestamp":1781342580,"startTime":"0","endTime":"0","summary":"南方财经6月13日电，诺和诺德今日宣布，其长效生长激素注射液诺泽优?（帕西生长激素）将于今年暑期在中国全面上市，为因内源性生长激素分泌不足所致生长迟缓的2.5岁及以上的中国儿童患者带来每周一次的治疗新选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606133770590837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVO","LU1093756325.SGD","BK4585","IE00BZ1G4Q59.USD","BK4532","LU0154236417.USD","IE00BKVL7J92.USD","NVOH","BK4007","NVOX","BK4599","BK4588","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182087964","title":"英国卫生监管机构批准诺和诺德减肥药Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=1182087964","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182087964?lang=zh_cn&edition=full","pubTime":"2026-06-11 23:19","pubTimestamp":1781191158,"startTime":"0","endTime":"0","summary":"英国药品监管机构周四批准了诺和诺德的减肥药片，为患者提供了一种无需注射的肥胖治疗新选择，同时也巩固了这家丹麦药企相对于美国竞争对手礼来的先发优势。诺和诺德预计，该药将在数周内通过私立处方上市。根据英国国家医疗服务体系的最新估算，英格兰约有30%的成年人受肥胖影响，相当于约1300万至1400万人。诺和诺德这款药片含有司美格鲁肽，与其旗下用于减肥的注射型重磅药物Wegovy及用于糖尿病的Ozempic具有相同的活性成分。","market":"us","thumbnail":"https://community-static.tradeup.com/news/4812f8e146094a91d24ad513651fcb26","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/4812f8e146094a91d24ad513651fcb26"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642424467","title":"减肥药概念股普涨 诺和诺德(NVO)涨3.14% 高盛料2030年全球减肥药市场规模将达1140亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642424467","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642424467?lang=zh_cn&edition=full","pubTime":"2026-06-10 22:17","pubTimestamp":1781101035,"startTime":"0","endTime":"0","summary":"高盛新近研究指，预计到2030年，全球减肥药市场规模将达到1140亿美元，较去年12月作出的1010亿美元预测进一步上调约13%，因一系列利好因素正在推动这一赛道从“小众高价市场”向“大众消费级市场”转变。基于这一趋势，高盛预计，到2030年口服减肥药将贡献约460亿美元收入，占全球肥胖症药物市场规模的40%，高于此前预计的350亿美元和35%的市场占比。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/ZjY1NDI1NzQxNDM1Mw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZjY1NDI1NzQxNDM1Mw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301402","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","NVOH","NVO","NVOX","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588","BK4007","LU1093756168.USD","BK4599","LU0154236417.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642419178","title":"GLP-1赛道竞争加剧  辉瑞“头对头”挑战诺和诺德","url":"https://stock-news.laohu8.com/highlight/detail?id=2642419178","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642419178?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:35","pubTimestamp":1781055326,"startTime":"0","endTime":"0","summary":"新华财经北京6月10日电近日，辉瑞公布其GLP-1受体激动剂埃诺格鲁肽（先维盈?）与诺和诺德司美格鲁肽（诺和盈?）的头对头研究——SLIMMER-UP-SWITCH的20周中期分析结果，显示埃诺格鲁肽在减重数值上略优于司美格鲁肽。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606103766030185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999002232.USD","LU0321505439.SGD","SG9999003800.SGD","IE00B3T34201.USD","IE00BLSP4239.USD","SG9999001176.USD","LU0154236417.USD","PFE","BK4550","SG9999011175.SGD","BK4533","LU0306807586.USD","IE00BLSP4452.SGD","LU0170899867.USD","LU0456855351.SGD","SG9999002224.SGD","LU0225284248.USD","LU0321505868.SGD","LU1057294990.SGD","BK4588","LU1023059063.AUD","BK4007","BK4568","IE0002270589.USD","LU0306806265.USD","IE000M9KFDE8.USD","LU1894683348.USD","LU1066051498.USD","LU1894683264.USD","SG9999001176.SGD","LU1883839398.USD","BK4534","LU1066053197.SGD","LU1093756168.USD","BK4532","IE00B19Z3B42.SGD","SG9999013999.USD","SGXZ57979304.SGD","LU2596442595.SGD","LU0225771236.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVOX","LU0122379950.USD","IE00BBT3K403.USD","BK4581","LU0289739699.SGD","BK4585","IE00B19Z3581.USD","LU0234572021.USD","NVO","IE00BKVL7J92.USD","LU0058720904.USD","LU0868494617.USD","NVOH","BK4592","LU0985481810.HKD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1248},{"period":"1month","weight":0.3427},{"period":"3month","weight":0.7233},{"period":"6month","weight":-0.2319},{"period":"1year","weight":-0.6592},{"period":"ytd","weight":-0.1891}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"2倍做多NVO ETF-Defiance","nameEN":"Defiance Daily Target 2X Long NVO ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"2倍做多NVO ETF-Defiance,NVOX,2倍做多NVO ETF-Defiance股票,2倍做多NVO ETF-Defiance股票老虎,2倍做多NVO ETF-Defiance股票老虎国际,2倍做多NVO ETF-Defiance行情,2倍做多NVO ETF-Defiance股票行情,2倍做多NVO ETF-Defiance股价,2倍做多NVO ETF-Defiance股市,2倍做多NVO ETF-Defiance股票价格,2倍做多NVO ETF-Defiance股票交易,2倍做多NVO ETF-Defiance股票购买,2倍做多NVO ETF-Defiance股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}